---
id: e5f6a7b8-9012-34ef-0123-5678901234ef
type: semantic
namespace: semantic/grants/project
created: 2026-01-05T11:00:00Z
modified: 2026-01-05T11:00:00Z
title: "NIH R01 CA-999999 - Metabolic Reprogramming in Cancer"
tags:
  - grant
  - nih
  - r01
  - cancer
  - metabolism
temporal:
  valid_from: 2025-07-01T00:00:00Z
  valid_until: 2030-06-30T00:00:00Z
  recorded_at: 2026-01-05T11:00:00Z
provenance:
  source_type: grant_award
  agent: claude-opus-4
  confidence: 0.98
citations:
  - type: documentation
    title: "NIH Reporter Grant Details"
    url: https://reporter.nih.gov/project-details/CA999999
    accessed: 2026-01-05T11:00:00Z
    relevance: 1.0
ontology:
  entity_type: grant
  entity_id: grant-nih-r01-ca999999
entity:
  title: "Metabolic Reprogramming in Pancreatic Cancer"
  agency: nih
  grant_number: "R01 CA999999"
  mechanism: "R01"
  pi_id: pi-smith-jane
  status: active
  total_budget: 2500000
  direct_costs: 1785714
  indirect_rate: 0.56
  project_period:
    start: "2025-07-01"
    end: "2030-06-30"
---

# NIH R01 CA-999999 - Metabolic Reprogramming in Cancer

Five-year R01 grant studying metabolic vulnerabilities in pancreatic
ductal adenocarcinoma (PDAC) for therapeutic targeting.

## Grant Overview

| Field | Value |
|-------|-------|
| **Grant Number** | R01 CA999999 |
| **Agency** | NIH/NCI |
| **Mechanism** | R01 |
| **PI** | Jane Smith, PhD |
| **Period** | 07/01/2025 - 06/30/2030 |
| **Total Budget** | $2,500,000 |
| **Annual Direct** | $357,143 |
| **F&A Rate** | 56% |

## Specific Aims

### Aim 1: Characterize Metabolic Dependencies
Map the metabolic landscape of KRAS-mutant PDAC cells using
metabolomics and CRISPR screening.

**Key Personnel:** Dr. Smith (PI), Dr. Chen (Co-I)
**Budget:** $800,000 (Years 1-3)

### Aim 2: Identify Therapeutic Targets
Validate top metabolic vulnerabilities as druggable targets
using genetic and pharmacological approaches.

**Key Personnel:** Dr. Smith (PI), Dr. Patel (Postdoc)
**Budget:** $900,000 (Years 2-4)

### Aim 3: Preclinical Validation
Test lead compounds in PDX mouse models of PDAC.

**Key Personnel:** Dr. Smith (PI), Dr. Kim (Collaborator)
**Budget:** $800,000 (Years 3-5)

## Key Milestones

| Year | Milestone | Status |
|------|-----------|--------|
| Y1 | Complete metabolomics profiling | Complete |
| Y1 | CRISPR screen optimization | In Progress |
| Y2 | Identify top 10 targets | Pending |
| Y3 | Lead compound selection | Pending |
| Y4 | PDX model validation | Pending |
| Y5 | Manuscript submission | Pending |

## Budget Summary

| Category | Annual | Total |
|----------|--------|-------|
| Personnel | $180,000 | $900,000 |
| Equipment | $40,000 | $200,000 |
| Supplies | $100,000 | $500,000 |
| Other | $37,143 | $185,715 |
| **Direct** | $357,143 | $1,785,714 |
| **F&A (56%)** | $142,857 | $714,286 |
| **Total** | $500,000 | $2,500,000 |

## Personnel Supported

| Name | Role | % Effort |
|------|------|----------|
| Jane Smith | PI | 25% |
| Wei Chen | Co-Investigator | 10% |
| Raj Patel | Postdoc | 100% |
| Maria Garcia | Graduate Student | 50% |
| Tom Wilson | Technician | 50% |

## Reporting Schedule

| Report | Due Date | Status |
|--------|----------|--------|
| Y1 Progress | 08/31/2026 | Pending |
| Y2 Progress | 08/31/2027 | - |
| Y3 Progress | 08/31/2028 | - |
| Y4 Progress | 08/31/2029 | - |
| Final Report | 08/31/2030 | - |

## Publications Citing This Grant

1. Smith J, et al. (2025) Nature Cancer. PMID: 12345678
2. Patel R, et al. (2026) Cell Metabolism. *In revision*

## Relationships

- leads [[project-aim1-metabolomics]]
- leads [[project-aim2-targets]]
- leads [[project-aim3-preclinical]]
- funded_by [[nih-nci]]
- produces [[dataset-metabolomics-2025]]
